Physician profile
Ginger Justice
NPI 1629230313
$5,641.53
in general payments reported to CMS, 2019-2025
11 companies · $4,398 in 2025
The $4,398 reported for 2025 was more than what 87% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $327 · 2023: $533 · 2024: $383 · 2025: $4,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,020 · Food and Beverage: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,020.00 |
| Food and Beverage | $1,294.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,045.97 | 2025 | |
| Aroa Biosurgery Incorporated | $855.83 | 2022-2025 | |
| Kerecis Limited | $295.45 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Depuy Synthes Sales INC. | $268.76 | 2023 | Matrixrib |
| Avita Medical Americas, LLC | $42.05 | 2025 | Permeaderm, Cohealyx, Recell |
| Integra Lifesciences Corporation | $34.30 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $24.78 | 2022 | |
| Davol INC. | $24.07 | 2023 | Phasix Mesh |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Innovation Technologies INC | $17.24 | 2024 | Irrisept |
| Conmed Corporation | $13.08 | 2024 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Justice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.